资讯

AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...
Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the ...
People living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.They also ...
AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s ...
Cancer cells can acquire energy-generating structures called mitochondria from nearby nerve cells, which seems to aid their ...
Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform ...
New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential Press ReleaseCarmil Therapeutics to develop next-generation immunotherapies ...
The US subsidiary will focus on advancing PolTreg's pipeline, including its lead candidate PTG-007 in type 1 diabetes, in these new territories.